Calcitonin negative neuroendocrine thyroid carcinoma: Case report and literature review

Authors

  • Erick Gonzales Laguado Head and Neck Department, Instituto Nacional de Enfermedades Neoplásicas. Lima, Peru.
  • Luis García Ruiz Surgical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas. Lima, Peru.
  • Henry Guerra Miller Pathology Department, Instituto Nacional de Enfermedades Neoplásicas. Lima, Peru
  • Jorge Luna-Abanto Surgical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas. Lima, Peru. https://orcid.org/0000-0001-8795-6635

DOI:

https://doi.org/10.20453/rmh.v32i2.3986

Abstract

Medullary thyroid carcinoma (MTC) is a relatively rare neuroendocrine tumor that originates in the parafollicular C cells of the thyroid gland. It is characterized by the synthesis and secretion of calcitonin. Usually, serum calcitonin is used as part of the diagnosis and follow-up of these patients. Few cases of MTC with negative calcitonin have been reported worldwide, whose diagnosis is a clinical challenge.

Downloads

Published

2021-07-19

How to Cite

1.
Gonzales Laguado E, García Ruiz L, Guerra Miller H, Luna-Abanto J. Calcitonin negative neuroendocrine thyroid carcinoma: Case report and literature review. Rev Méd Hered [Internet]. 2021 Jul. 19 [cited 2024 Apr. 25];32(2):119-23. Available from: https://revistas.upch.edu.pe/index.php/RMH/article/view/3986

Issue

Vol. 32 No. 2 (2021): April-June

Section

CASE REPORTS

License

Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.